Award
Delivery Order #SPE2DR26FFCB5
DMS Pharmaceutical Group Delivery Order for NUCALA Syringe
Buyer
Defense Logistics Agency
Award Amount
$1,931.83
Ceiling
$1,931.83
Awarded
February 12, 2026
Period of Performance
Feb 12, 2026 – Feb 13, 2026
Identifier
SPE2DR26FFCB5
NAICS
424210
This award is a delivery order contract under an existing indefinite delivery vehicle (IDV) with DMS Pharmaceutical Group Inc., a pharmaceutical supplier with expertise in providing specialized medications. The contract procures NUCALA 100 MG/ML syringes, a medication relevant for specific therapeutic treatments. This delivery order supports the agency's ongoing pharmaceutical supply chain efforts by ensuring availability of critical drugs on a short-term basis. The scope covers the immediate provision and delivery of the specified pharmaceutical product to a designated location in Park Ridge, Illinois. The contract is a continuation of services under the prior IDV contract, which was awarded without competitive bidding due to the specialized nature of pharmaceutical services required. The performance period for this delivery order spans a concise timeframe from mid to late February in 2026, aligning with the agency's immediate medication needs.
Description
4570821842!NUCALA 100 MG/ML SYRINGEML